Company Filing History:
Years Active: 2016-2020
Title: Tani Lee: Innovator in Cancer Treatment Technologies
Introduction
Tani Lee is a prominent inventor based in San Diego, CA, who has made significant contributions to the field of cancer treatment technologies. With a focus on innovative methods for predicting responses to therapies, her work has the potential to greatly impact cancer diagnosis and treatment.
Latest Patents
Tani Lee holds 3 patents that showcase her expertise in cancer research. Her latest patents include:
1. **Methods for predicting response of triple-negative breast cancer to therapy** - This invention provides compositions and methods for detecting the expression and/or activation levels of components of signal transduction pathways in tumor cells, particularly in triple-negative metastatic breast tumor cells. The information derived from this invention can be utilized for cancer diagnosis, prognosis, and the design of effective cancer treatments.
2. **Biomarkers for determining sensitivity of breast cancer cells to HER2-targeted therapy** - This patent offers compositions and methods for detecting the expression and/or activation states of components of signal transduction pathways in tumor cells. Similar to her previous work, this invention aids in cancer diagnosis, prognosis, and the development of targeted cancer therapies.
Career Highlights
Throughout her career, Tani Lee has worked with notable companies such as Nestlé S.A. and Pierian Holdings, Inc. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in cancer treatment.
Collaborations
Tani has collaborated with esteemed colleagues, including Xinjun Liu and Phillip Kim. These partnerships have fostered an environment of innovation and have led to advancements in cancer research.
Conclusion
Tani Lee's contributions to cancer treatment technologies through her patents and collaborations highlight her role as a leading inventor in the field. Her work continues to pave the way for improved cancer diagnosis and therapies, making a significant impact on patient care.